Pediatric selective mutism therapy: a randomized controlled trial

Maria Esposito1, Francesca Gimigliano2, Maria R Barillari3

  • 1Clinic of Child and Adolescent Neuropsychiatry, Department of Mental Health, Physical and Preventive Medicine, Second University of Naples, Naples, Italy.

Insights

Psychomotor treatment significantly reduced anxiety and improved social interactions in children with selective mutism (SM). This therapy offers a safe and effective approach for pediatric SM rehabilitation.

Area of Science:

  • Pediatric Psychiatry
  • Child Psychology
  • Developmental Neuroscience

Background:

  • Selective mutism (SM) is a rare childhood anxiety disorder with significant functional impairment.
  • Current treatment options for SM are limited, highlighting the need for effective interventions.

Purpose of the Study:

  • To evaluate the efficacy of a six-month standard psychomotor treatment for children with SM.
  • To assess associated lifestyle changes and their impact on SM symptoms.

Main Methods:

  • A randomized controlled trial involving 138 children with SM was conducted.
  • Participants received either psychomotor treatment or behavioral/educational counseling for six months.
  • Child Behavior Checklist (CBCL) and Selective Mutism Questionnaire (SMQ) were used for assessments.

Main Results:

  • Psychomotor treatment led to significant reductions in CBCL scores for social relations, anxiety/depression, and overall problems.
  • SMQ assessments showed a significant decrease in SM symptoms across school, family, and social settings.
  • Improvements were observed in withdrawn behavior and internalizing problems.

Conclusions:

  • Psychomotor treatment demonstrates a positive effect as part of a rehabilitative program for children with selective mutism.
  • This study identifies psychomotricity as a safe and effective therapy for pediatric SM.
  • Further research is warranted to confirm these preliminary findings.
Abstract

Related Concept Videos